Delivery Order SPE2DB22D2206-SPE2DB24FER39
Award Date 12/16/23
Potential Completion Date 12/18/23
Potential Value $13K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pen 2 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,159.91 and a period of performance through February 19, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price pricing type. The contract is not associated with a set-aside...
- The federal contract award is for the delivery of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product, to support military and federal healthcare programs. The award, valued at $18,948.48, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a delivery order contract with a firm fixed price pricing type, and an ultimate completion date of January 24, 2024. The contract is not designated with any...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pen, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The $13,717.44 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 16, 2025 with a completion date of July 17, 2025. This is a delivery order contract that is not set aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pen medication to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price and a ceiling value of $71,954.88. The contract has an ultimate completion date of December 27, 2023, and was awarded on December 26, 2023. This contract is not designated as a...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pens to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $14,115.23 and an ultimate completion date of November 4, 2022. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- The federal contract award is for the delivery of Dupixent 300 mg/2 ml pens to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $35,577.02 and is a Firm Fixed Price Delivery Order. It does not have a set-aside designation, indicating open competition. The contract is associated with a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pen, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,652.35 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 17, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pen 2 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,242.91 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of February 29, 2024 and was awarded on February 28, 2024. This appears to be part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that...
- This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, with a ceiling value of $80,235.95. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed-price pricing type, and an ultimate completion date of March 4, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pens to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,418.92 and runs through November 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...